(Q34227843)

31 July 2017

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells (English)

1 reference

31 July 2017

5

1 reference

31 July 2017

6

Felix Hoppe-Seyler

1 reference

31 July 2017

Karin Butz

1

1 reference

31 July 2017

Tutik Ristriani

series ordinal

2

1 reference

31 July 2017

Arnd Hengstermann

series ordinal

3

1 reference

31 July 2017

Claudia Denk

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

31 July 2017

1 reference

31 July 2017

22

1 reference

31 July 2017

38

1 reference

31 July 2017

5938-5945

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206894

31 July 2017

0 references

cites work

Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

Death and anti-death: tumour resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

Translocating peptides and proteins and their use for gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Stable suppression of tumorigenicity by virus-mediated RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

High-efficiency transformation of mammalian cells by plasmid DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Analysis of gene function in somatic mammalian cells using small interfering RNAs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Proliferation, cell cycle and apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

A transcriptionally active DNA-binding site for human p53 protein complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Modulation of HIV-1 replication by RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

The human papillomavirus E6 protein and its contribution to malignant progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Control of pRB phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

From bench to clinic with apoptosis-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

siRNA-directed inhibition of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

RNA interference: the new somatic cell genetics?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Cancer burden in the year 2000. The global picture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Apoptosis-regulating proteins as targets for drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Inhibition of Bak-induced apoptosis by HPV-18 E6.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

The role of the E6-p53 interaction in the molecular pathogenesis of HPV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206894

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206894

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference